Skin longevity brand LNGVTY has raised Rs 5 crore in a seed funding round led by Rukam Capital, the company said on Sunday. The Mumbai-based startup will deploy the capital toward strengthening its direct-to-consumer marketing, expanding its product line, investing in research and development, and building out its founding team to accelerate growth across India.
What LNGVTY does
Founded by Nishit Ratthe, LNGVTY positions itself in the emerging skin longevity segment — a departure from quick-fix beauty toward evidence-based, long-term skin health. Its debut offering, Skin Longevity System 5, is built around five biological pathways linked to skin renewal, repair, and resilience.
The platform currently includes three serums targeting acne and blemish control, dark spots and pore control, and deep hydration and glow, all built on a common formulation. The products have undergone independent third-party testing over a 75-day usage protocol, the company said.
Why it matters
India's skincare market, valued at over $9 billion in 2025 and projected to reach nearly $18.4 billion by 2034, is moving toward science-backed, protocol-driven products — a shift that creates openings for brands selling measurable outcomes rather than cosmetic promises.
For global buyers, distributors, and investors watching the India–Gulf corridor, LNGVTY represents an early bet on "skin longevity" as a distinct category, not just another D2C skincare label. The seed-stage backing from a consumer-focused fund like Rukam Capital signals institutional appetite for brands that marry biological rigour with digital-first distribution.
Whether a 75-day serum protocol can command consumer patience and repeat purchase at scale remains the question the next 18 months will answer.